Bruce & Co’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$481K	Sell	429,188 -120,812	-22%	-$135K	0.16%	39
2025 Q1	$435K	Buy	550,000 +200,000	+57%	+$158K	0.14%	38
2024 Q4	$578K	Hold	350,000	–	–	0.19%	36
2024 Q3	$1.23M	Buy	350,000 +50,000	+17%	+$175K	0.36%	32
2024 Q2	$984K	Buy	300,000 +157,000	+110%	+$515K	0.32%	32
2024 Q1	$1.05M	Hold	143,000	–	–	0.35%	30
2023 Q4	$535K	Sell	143,000 -57,000	-29%	-$213K	0.19%	34
2023 Q3	$424K	Hold	200,000	–	–	0.14%	35
2023 Q2	$956K	Hold	200,000	–	–	0.27%	28
2023 Q1	$1.14M	Buy	200,000 +143,000	+251%	+$815K	0.31%	27
2022 Q4	$575K	Hold	57,000	–	–	0.15%	32
2022 Q3	$1.28M	Hold	57,000	–	–	0.35%	27
2022 Q2	$1.41M	Hold	57,000	–	–	0.33%	27
2022 Q1	$2.21M	Hold	57,000	–	–	0.45%	25
2021 Q4	$3.34M	Hold	57,000	–	–	0.67%	23
2021 Q3	$3.38M	Sell	57,000 -5,000	-8%	-$296K	0.72%	24
2021 Q2	$5.38M	Sell	62,000 -3,000	-5%	-$260K	1.03%	20
2021 Q1	$5.36M	Sell	65,000 -10,000	-13%	-$824K	1%	21
2020 Q4	$6.82M	Sell	75,000 -25,000	-25%	-$2.27M	1.31%	20
2020 Q3	$4M	Hold	100,000	–	–	0.83%	24
2020 Q2	$3.43M	Buy	100,000 +50,000	+100%	+$1.72M	0.75%	24
2020 Q1	$1.11M	Hold	50,000	–	–	0.26%	34
2019 Q4	$978K	Buy	+50,000	New	+$978K	0.19%	37